CPIX: שווי חברה לרווח נקי Cumberland Pharma

Cumberland Pharmaceuticals (CPIX) is a recognized leader in the US hospital sector, having earned the trust of clinics through the uncompromising quality of its antidotes and anesthetics. The price history confirmed by this chart on GURU.Markets, where the indicator stands at -7.40, is based on a production outsourcing model that eliminates raw material shortages. Business growth relies on expanding the list of FDA approvals and the commercialization of effective drugs, such as Vibativ and Vaprisol.

The ratio of market capitalization to earnings per share determines the capital payback period, measuring the efficiency of the asset's pricing relative to its actual income. For Cumberland Pharmaceuticals (CPIX), this calculation reflects business resilience, where exclusive hospital supply rights minimize the impact of generics, allowing investors to assess fundamental undervaluation through the company's earnings multiple.